Core Viewpoint - Anselme Limited has increased its stake in Huakang Biomedical (08622) to 51.84% by acquiring 138.672 million shares at an average price of HKD 0.126 per share, totaling approximately HKD 17.47 million [1] Group 1 - Anselme Limited's recent acquisition involved purchasing 138.672 million shares of Huakang Biomedical [1] - The average price per share for this transaction was HKD 0.126 [1] - Following this transaction, Anselme Limited's total shareholding in Huakang Biomedical is approximately 259 million shares [1] Group 2 - The total amount spent by Anselme Limited for this acquisition was around HKD 17.47 million [1] - The new shareholding percentage of Anselme Limited in Huakang Biomedical is 51.84% [1] - The transaction also involved other related parties, specifically Zhou Xun Yong [1]
Anselme Limited增持华康生物医学约1.39亿股 每股均价0.126港元